Results from multivariable regression models of the effect of adverse childhood experiences (ACEs) during ages 0–20 years on clinical outcomes of multiple sclerosis. حسب Mary K. Horton (11944309)

الموضوعات:

Baseline characteristics among multiple sclerosis (MS) cases and controls in the Kaiser Permanente Northern California MS Research Program, 2006–2014 (n = 2607). حسب Mary K. Horton (11944309)

الموضوعات:

Groupings of statistically significantly associated proteins by their biological processes. حسب Alish B. Palmos (5857379)

Ivermectin significantly decreases <i>L</i>. <i>loa</i> mf in BALB/c mice. حسب Rene Bilingwe Ayiseh (6900296)

Significant Decrease in Vessel Count of Trade Vessels in (a) Bosporus Strait and (b) Bab el-Mandeb Strait. حسب Cherryl Chico (20978829)

Nineteen SNPs with significant association (<i>P < </i>5 × 10⁻⁸) with risk on minJSW decrease in knee OA. حسب Mieke L. M. Bentvelzen (21594442)

"…<p>Nineteen SNPs with significant association (<i>P < </i>5 × 10⁻⁸) with risk on minJSW decrease in knee OA.…"

Flow diagram of the study identification process. حسب Luz Estella Mesa (8339283)

الموضوعات:

Overall characteristics of the included studies. حسب Luz Estella Mesa (8339283)

الموضوعات:

Summary of active RA clinical trials with MSC therapy that included a control group. حسب Luz Estella Mesa (8339283)

الموضوعات:

GRADE assessment. حسب Luz Estella Mesa (8339283)

الموضوعات:

Significantly changed AS events in the muscle and neural-related genes in the <i>sf3b1</i> mutants. حسب Bei Zhang (428038)

Myelinopathy results in a significantly reduced spike probability and increased latency after a release event. حسب Maral Budak (6680351)

Adverse health events. حسب Harika Dasari (18145735)

الموضوعات:

Time-varying effect of anti-coagulation regime on sub-distribution hazards for all-cause mortality. حسب Simon de Lusignan (2416)

الموضوعات:

Unadjusted cumulative incidence of stroke and all-cause mortality by type of anti-coagulant. حسب Simon de Lusignan (2416)

الموضوعات:

Summary of multivariate adjusted cause-specific hazards and the subdistribution hazards for comparison. حسب Simon de Lusignan (2416)

الموضوعات:

Crude incidence rates of stroke and all-cause mortality. حسب Simon de Lusignan (2416)

الموضوعات:

Time-Varying effect of anti-coagulation regimen on sub-distribution hazards for stroke. حسب Simon de Lusignan (2416)

الموضوعات:

Unadjusted cumulative incidence of stroke and all-cause mortality. حسب Simon de Lusignan (2416)

الموضوعات:

Multivariate analysis of the cause-specific hazard ratio (CSHR) for all-cause mortality, interpreted as time-averaged effects. حسب Simon de Lusignan (2416)

الموضوعات: